Morgan Stanley on Tuesday shifted its stance on Royal Unibrew A/S (CSE:RBREW), moving the stock from an "overweight" designation to "equal-weight." The change reflects the brokerage's view that the Danish beverage producer's shares have rerated materially over the last six months, leaving less room for additional gains.
The firm lifted its price target slightly to 595 Danish crowns from 580 crowns, but noted that the share price, trading at 609.50 crowns, already appears to incorporate the earnings improvement that formed the basis of its bullish call since October 2025. Shares of Royal Unibrew were down 1.6% at 07:38 ET (12:38 GMT).
In its note, Morgan Stanley described the risk-reward profile as "balanced." The bank highlighted that Royal Unibrew had re-rated by 9 percentage points versus European consumer staples during the prior six months, ranking among the largest sector moves. As a result, the stock now trades in line with consumer staples peers on estimated 2026 price-to-earnings, whereas it had a 12% discount when Morgan Stanley first initiated an overweight rating in early October.
The research team also trimmed its forward profit forecasts. Across 2026-29, Morgan Stanley reduced its EBIT estimates by 1% on average and cut earnings per share by about 4% on average. The revisions reflect the brokerage's adoption of softer revenue assumptions, expectations for higher financing costs and an increased share count.
Operationally, Royal Unibrew's fourth-quarter organic sales growth of 4% fell short of a 7% consensus. Regionally, Northern Europe - a core division that represents a sizable portion of group revenue alongside Western Europe - expanded just 1% organically in the quarter, against a 5% market expectation. Western Europe recorded 7% organic growth, which also missed the 9% consensus despite an easier year-earlier comparison.
Analysts at Morgan Stanley noted management's move to stop providing net revenue guidance as a factor warranting attention. On the company's full-year results call, Royal Unibrew management said net revenue in 2026 would be "broadly in line with 2025," and disclosed that exiting lower-margin activities would reduce group revenue by around 3.5% with no impact on EBIT or volumes. The exits are expected to primarily affect the Northern European snacks business.
Based on its updated assumptions, Morgan Stanley now forecasts 2026 revenue of 15.83 billion crowns, EBIT of 2.39 billion crowns and earnings per share of 34 crowns. Those figures imply a forward price-to-earnings multiple of 17.2 times, which the bank notes is roughly a 5% premium to European consumer staples - a shift from a 1% historical discount.
The brokerage's 595-crown price target is a blend of valuation approaches: a discounted cash flow (DCF) valuation of 630 crowns, which uses an 8.4% weighted average cost of capital and a 2.5% terminal growth rate, combined with a multiple-based valuation of 556 crowns applying 17.5 times forward earnings. Morgan Stanley's bull and bear case valuations are 780 crowns and 410 crowns respectively. The bear scenario applies a 14.7 times multiple to a 12.7% EBIT margin, characterized as the decade-low outside the pandemic period.
Across the analyst community tracked by Refinitiv, 69% rate the stock "overweight," 25% "equal-weight" and 6% "underweight." Published price targets among those analysts range from 425 to 720 crowns.
Market and sector context
The combined effect of a high absolute share price relative to the new target, the recent rerating versus staples peers, and downgraded earnings assumptions underpin Morgan Stanley's view that further near-term upside is limited. The developments touch investor sentiment toward consumer staples and beverage companies operating in Europe, where regional volume and margin dynamics vary by market.